Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Other hematologic neoplasm 1 Gynecologic 1 Genitourinary 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 581 Carboplatin 528 Cisplatin 359 Bevacizumab 257 pembrolizumab 228 Gemcitabine 157 liposomal doxorubicin 132 Topotecan 131 olaparib 129 Cyclophosphamide 128 Radiotherapy 118 Taxes 114 Docetaxel 95 Brachytherapy 94 Drug Therapy 91 niraparib 88 Doxorubicin 86 Surveys and Questionnaires 85 Magnetic Resonance Spectroscopy 81 Blood Specimen Collection 74 Specimen Handling 71 Nivolumab 71 Hyperthermic Intraperitoneal Chemotherapy 64 Biopsy 63 fludarabine 57 Filgrastim 53 Letrozole 50 Oxaliplatin 49 durvalumab 47 Immunoglobulin G 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glutamyl Aminopeptidase × Gynecologic × Clear all

NCT05415527 2026-01-29

OPTIMOVA

Institut Bergonié

Phase NA Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡